tersolisib
tersolisib: 2 clinical trials tracked.
tersolisib evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
What is verified about tersolisib, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (2)
A Phase 1, Open-label Study to Assess the Effect of Food on the Pharmacokinetics of Tersolisib Administered Under Fasted Conditions, With a High-fat Meal, and With a Low-fat Meal, in Healthy Participants
Primary endpoint: Pharmacokinetics (PK): Maximum Concentration (Cmax) of Tersolisib
First-in-Human Study of STX-478, a Mutant-Selective PI3Kα Inhibitor as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Primary endpoint: Number of participants who experience at least 1 Dose Limiting Toxicity (DLT)